Approval · Notice of Compliance 5404 · 2003
PANTOLOC: Notice of Compliance 5404
Issued October 15, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5404
- Date
- October 15, 2003
- Company
- Solvay Pharma Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- New indication: prevention of gastrointestinal lesions induced by non-steroidal anti-inflammatory drugs in patients with a need for continuous nsaid therapy
- Therapeutic class
- H+, k+-atpase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PANTOLOC | Not yet assigned | — |
Medicinal ingredients
- PANTOPRAZOLE SODIUM 20 MG per TAB